NRX Pharmaceuticals Analyst Ratings

BenzingaSep 13 01:55 · Ratings

Express News | NRX Pharmaceuticals Inc : Ascendiant Capital Markets Raises Target Price to $44 From $43

BreakingsSep 12 14:16

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com

PR NewswireSep 11 19:55

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, Inc. Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024

PR NewswireSep 3 19:55

HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion

BenzingaAug 27 06:48

NRX Pharmaceuticals Secures Non-Binding Debt Financing Agreements for Ketamine Clinics

MT NewswiresAug 26 21:02